Luminist Labs YC Demo Day (W16) - Diagnostic platform for early detection of liver disease
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
![[500 STARTUPS DEMO DAY 2016] BATCH 18, Track](https://img.youtube.com/vi/DH-S9qEfS1A/0.jpg)
![[500 STARTUPS DEMO DAY 2017] BATCH 20, Orderly Health](https://img.youtube.com/vi/T87AeBdI6fs/0.jpg)
